Management of Sjogren's Dry Eye Disease-Advances in Ocular Drug Delivery Offering a New Hope
Sjögren's syndrome is a chronic and insidious autoimmune disease characterized by lymphocyte infiltration of exocrine glands. Patients typically present with dry eye, dry mouth, and other systemic manifestations. Currently, the available molecules and drug-delivery systems for the treatment of...
Saved in:
Main Authors: | Kevin Y. Wu (Author), Wei T. Chen (Author), Y-K (Author), Gauri Patel (Author), Simon D. Tran (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2022-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
What's New in Ocular Drug Delivery: Advances in Suprachoroidal Injection since 2023
by: Kevin Y. Wu, et al.
Published: (2024) -
A focus on Sjogren's Dry Eye Disease - pathogenesis, patient management, and new advancements in therapy
by: Ewa Uram, et al.
Published: (2023) -
A New Era in Ocular Therapeutics: Advanced Drug Delivery Systems for Uveitis and Neuro-Ophthalmologic Conditions
by: Kevin Y. Wu, et al.
Published: (2023) -
Development and content validity assessment of the Dry Eye Disease Questionnaire in patients with dry eye disease, meibomian gland dysfunction, and Sjögren's syndrome dry eye disease
by: Brigitte Sloesen, et al.
Published: (2023) -
Ocular Pharmacological Profile of Hydrocortisone in Dry Eye Disease
by: Claudio Bucolo, et al.
Published: (2019)